Literature DB >> 30549173

Prevalence and correlates of a positive screen for eating disorders among Syrian refugees.

Antoine Aoun1, Janine Joundi1, Najwa El Gerges1.   

Abstract

The objective of this cross-sectional study was to examine the prevalence and correlates of a positive screen for eating disorders (EDs) in a sample of Syrian refugees living in North Lebanon. The study was conducted on a convenience sample of 450 (84.67% women and 15.33% men) refugees, aged between 18 and 45 years. The prevalence of a positive screen for ED was 5.79%. Bivariate analyses revealed that female gender (p = 0.02), presence of medical conditions (p = 0.01), old occurrence of major stressful life event (p < 0.01), and positive primary care post-traumatic stress disorder screen (p < 0.01) were associated with the positive sick, control, one stone, fat, food tool. Multiple logistic regression analyses showed that subjects screened with post-traumatic stress disorder had a three times higher risk of having a positive screen for ED (odds ratio = 3.2; 95% confidence interval [1.32, 7.78]). Early detection of ED and related factors may help identify refugees who would benefit from interventions to improve mental health.
© 2018 John Wiley & Sons, Ltd and Eating Disorders Association.

Entities:  

Keywords:  correlates; eating disorders; post-traumatic stress disorder; refugees; screening

Mesh:

Year:  2018        PMID: 30549173     DOI: 10.1002/erv.2660

Source DB:  PubMed          Journal:  Eur Eat Disord Rev        ISSN: 1072-4133


  2 in total

1.  COVID-19 and implications for eating disorders.

Authors:  Fernando Fernández-Aranda; Miquel Casas; Laurence Claes; Danielle Clark Bryan; Angela Favaro; Roser Granero; Carlota Gudiol; Susana Jiménez-Murcia; Andreas Karwautz; Daniel Le Grange; Jose M Menchón; Kate Tchanturia; Janet Treasure
Journal:  Eur Eat Disord Rev       Date:  2020-05

Review 2.  Vulnerabilities of Arab refugees in primary health care: a scoping review.

Authors:  Luiz Paulo de Lima Junior; Kayte Chaves Oliveira de Lima; Maria Rita Bertolozzi; Francisco Oscar de Siqueira França
Journal:  Rev Saude Publica       Date:  2022-04-01       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.